» Articles » PMID: 19669093

Regulation of Estrogen Receptor Beta Activity and Implications in Health and Disease

Overview
Publisher Springer
Specialty Biology
Date 2009 Aug 12
PMID 19669093
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Together with the estrogen receptor (ER) alpha, estrogen receptor beta (ER beta ) mediates many of the physiological effects of estrogens. As ER beta is crucially involved in a variety of important physiological processes, its activity should be tightly regulated. ER beta regulation is achieved by hormone binding as well as by posttranslational modifications of the receptor. Furthermore, ER beta expression levels are under circadian control and can be regulated by DNA methylation of the ER beta promoter region. There are also a number of factors that can interfere with ER beta activity, such as phytoestrogens, endocrine disruptive chemicals, and growth factors. In this article, we outline different mechanisms of ER beta regulation and how they are implicated in various diseases. We also discuss how these insights might help to specifically target ER beta in drug design.

Citing Articles

Unanticipated differences in the rat plasma metabolome of genistein and daidzein.

Montoya G, van Ravenzwaay B, Seefelder W, Haake V, Kamp H Arch Toxicol. 2025; .

PMID: 39954026 DOI: 10.1007/s00204-025-03967-8.


Role of estrogen receptors in health and disease.

Chen P, Li B, Ou-Yang L Front Endocrinol (Lausanne). 2022; 13:839005.

PMID: 36060947 PMC: 9433670. DOI: 10.3389/fendo.2022.839005.


Y It Matters-Sex Differences in Fetal Lung Development.

Laube M, Thome U Biomolecules. 2022; 12(3).

PMID: 35327629 PMC: 8946560. DOI: 10.3390/biom12030437.


Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.

Bozovic A, Mandusic V, Todorovic L, Krajnovic M Int J Mol Sci. 2021; 22(4).

PMID: 33562134 PMC: 7914503. DOI: 10.3390/ijms22041656.


The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer.

Chen Y, Huang Y, Huang H, Chang H, Lee S, Shieh Y J Cancer Res Clin Oncol. 2020; 146(5):1299-1306.

PMID: 32107626 DOI: 10.1007/s00432-020-03162-5.


References
1.
Driggers P, Segars J, Rubino D . The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway. J Biol Chem. 2001; 276(50):46792-7. PMC: 4152864. DOI: 10.1074/jbc.M106927200. View

2.
Seo H, DeNardo D, Jacquot Y, Laios I, Vidal D, Zambrana C . Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat. 2006; 99(2):121-34. DOI: 10.1007/s10549-006-9191-2. View

3.
Safe S, Wormke M . Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol. 2003; 16(7):807-16. DOI: 10.1021/tx034036r. View

4.
Noren K, Meironyte D . Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere. 2000; 40(9-11):1111-23. DOI: 10.1016/s0045-6535(99)00360-4. View

5.
Welshons W, Nagel S, Vom Saal F . Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006; 147(6 Suppl):S56-69. DOI: 10.1210/en.2005-1159. View